-
Mashup Score: 0Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development - 5 day(s) ago
Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development Biopharmaceutical company Trace Neuroscience announced it
Source: seniorhousingnews.comCategories: General Medicine News, Rare DiseaseTweet
https://t.co/OkkKmqDIXb